These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10068201)

  • 21. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
    Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
    Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults.
    Jha P; Suri V; Singh G; Jha P; Purkait S; Pathak P; Sharma V; Sharma MC; Suri A; Gupta D; Mahapatra AK; Sarkar C
    Diagn Mol Pathol; 2011 Dec; 20(4):225-32. PubMed ID: 22089350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
    Biernat W; Kleihues P; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):180-5. PubMed ID: 9034372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
    Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY
    J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIK3CA alterations in primary (de novo) and secondary glioblastomas.
    Kita D; Yonekawa Y; Weller M; Ohgaki H
    Acta Neuropathol; 2007 Mar; 113(3):295-302. PubMed ID: 17235514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analysis of a multifocal glioblastoma multiforme: a suitable tool to gain new aspects in glioma development.
    Krex D; Mohr B; Appelt H; Schackert HK; Schackert G
    Neurosurgery; 2003 Dec; 53(6):1377-84; discussion 1384. PubMed ID: 14633303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alterations in primary glioblastomas in Japan.
    Fukushima T; Favereaux A; Huang H; Shimizu T; Yonekawa Y; Nakazato Y; Ohagki H
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):12-8. PubMed ID: 16410744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
    Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
    J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
    Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway.
    Das A; Tan WL; Teo J; Smith DR
    J Neurooncol; 2002 Nov; 60(2):117-25. PubMed ID: 12635658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of PTEN nonsense mutation and psiPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay.
    Zhang CL; Tada M; Kobayashi H; Nozaki M; Moriuchi T; Abe H
    Oncogene; 2000 Sep; 19(38):4346-53. PubMed ID: 10980610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
    Raffel C; Frederick L; O'Fallon JR; Atherton-Skaff P; Perry A; Jenkins RB; James CD
    Clin Cancer Res; 1999 Dec; 5(12):4085-90. PubMed ID: 10632344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
    Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
    Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.
    Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R
    Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
    Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
    Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
    Kraus JA; Felsberg J; Tonn JC; Reifenberger G; Pietsch T
    Neuropathol Appl Neurobiol; 2002 Aug; 28(4):325-33. PubMed ID: 12175345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent molecular development of metachronous glioblastomas with extended intervening recurrence-free interval.
    Martinez R; Schackert HK; von Kannen S; Lichter P; Joos S; Schackert G
    Brain Pathol; 2003 Oct; 13(4):598-607. PubMed ID: 14655763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells.
    Fan X; Furnari FB; Cavenee WK; Castresana JS
    Int J Oncol; 2001 May; 18(5):1023-6. PubMed ID: 11295051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.